Biotheranostics logo
WebApr 19, 2024 · Biotheranostics Inc. has agreed to pay $2 million to resolve allegations that it submitted and caused the submission of false claims to Medicare for Breast Cancer Index (BCI) tests that were not reasonable and necessary for the diagnosis and treatment of breast cancer, the Department of Justice announced today. Biotheranostics is a … WebCancerTYPE ID ® is a proprietary molecular assay using RT-PCR to measure expression of 92 genes. To classify the tumor, the gene expression profile is matched to a database of more than 2000 known tumor types and subtypes. Using this technology, CancerTYPE ID ® can identify 50 different tumor types and subtypes, covering >95% of all solid ...
Biotheranostics logo
Did you know?
WebJan 6, 2024 · Published. Jan 6, 2024 1:28AM EST. M edical technology company Hologic Inc. has announced the acquisition of privately-held Biotheranostics Inc. in a deal worth $230 million. Shares of Hologic ... WebInterview. Rather than a panel interview, I had four half-hour interviews with: 1. Histotechnologist and Histology Associate 2. Lab Director and VP of Laboratory Operations 3. Medical Director 4. Human Resources During …
WebJan 5, 2024 · – Transaction Accelerates Hologic’s Entry into Oncology Growth Market, Provides New Lab Capabilities – – Hologic’s Commercial Resources, Expertise in … WebApr 19, 2024 · The United States alleged that Biotheranostics Inc. — a diagnostic laboratory testing company — knowingly promoted and performed the Breast Cancer Index test for breast cancer patients who …
WebJan 6, 2024 · Hologic announced late Tuesday its acquisition of Biotheranostics for $230 million, marking the second tuck-in for the medical device maker less than a week into 2024. The deal is expected to close in February. Biotheranostics is a privately-held company that sells molecular diagnostics tests for breast and metastatic cancers. Hologic said the ... WebBiotheranostics was acquired by Hologic in February 2024, and continues to offer its portfolio of proprietary genomic assays to support personalized disease management in …
WebBiotheranostics, Inc. has been acquired by Hologic. Hologic is an innovative medical technology company whose purpose is to enable healthier lives everywhere, every day. While we discover and ...
WebBiotheranostics is a molecular diagnostics company that develops and provides diagnostic, prognostic, and predictive tests that helps physicians in the treatment of cancer patients. It offers CancerTYPE ID, a gene expression test for metastatic patients with diagnostic ambiguity, and Breast Cancer Index, a tool for breast cancer patients. highflower srlWebMar 13, 2024 · Biotheranostics doesn't have any recent trademark applications, indicating Biotheranostics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and … high flow cpap machineWebJan 5, 2024 · Biotheranostics, Inc. is a commercial-stage molecular diagnostics company that develops and provides diagnostic, prognostic and predictive tests that support … high flow diesel fuel pumpsWebJan 19, 2024 · Contact Data Lisa Whitmyer Biotheranostics, Inc. 216-513-7808 [email protected] high flower ขอนแก่นWebThis test is used for clinical purposes, and should not be regarded as experimental or investigational. How this information is used to guide patient care is the responsibility of … highflowers leesburg alWebFeb 22, 2024 · - Breast Cancer Index ™ Added to National Comprehensive Cancer Network Guidelines to Predict Benefit from Extended Endocrine Therapy - Hologic, Inc. (Nasdaq: … highflowerWeb2 days ago · Biotheranostics Illumina DNA Link Genomic Health, Inc.(Exact Sciences) Cypher Genomics(Human Longevity, Inc.) Life Technologies Corporation(Thermo Fisher Scientific) ... high flower bed